3D Bioprinting Market 2030 by Component (3D Bioprinters, and Bioinks), Technology (Stereolithography, Selective Laser Sintering, Electron Beam Melting, Fused Deposition Modeling, Laminated Object Manufacturing, Inkjet Printing, and Multi-phase Jet Solidification), Materials (Living Cells, Extracellular Matrices, and Hydrogels), Application, End user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

3D Bioprinting Market size is estimated to grow from USD 1.8 Billion in 2022 to reach USD 2.1 Billion by 2030, growing at a CAGR of 17.3% during the forecast period from 2023 to 2030.

Major players 3D Bioprinting Market include: Envisiontec, Inc., Organovo, Inventia Life Science Pty Ltd, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L., BICO Group AB, Organovo Holdings Inc., CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd., Advanced Solutions Life Sciences, LLC, Regenovo Biotechnology Co., Ltd. and Others.

3D bioprinting is experiencing a growing presence within the cosmetics and pharmaceutical industries

3D bioprinting is experiencing a growing presence within the cosmetics and pharmaceutical industries. Numerous pharmaceutical companies are swiftly adopting 3D bioprinting technologies and products to expedite the discovery and development of novel drugs. In comparison to traditional drug testing methods, 3D bioprinting offers a more cost-effective and secure approach for drug evaluation. By leveraging the 3D bioprinting approach, pharmaceutical firms can assess the effectiveness of medications in a matter of hours, significantly reducing the typical three to six years required for new drug development. This innovative technique empowers research and development teams to test new medications both in early stages and during preclinical studies using 3D bioprinted tissues. The benefits encompass a decrease in reliance on animal testing, heightened efficiency, and an accelerated drug development process. The growing utilization of 3D printing is fostering a deeper understanding of this technology, particularly in the cosmetics domain. Moreover, spurred by the European Commission's prohibition of animal testing for cosmetics since March 2013, various enterprises in the cosmetics and healthcare sectors are embracing 3D bioprinting to establish cutting-edge 3D tissue models and methodologies for drug screening.

Rising demand for organ transplants

The realm of 3D bioprinting is experiencing rapid expansion within the medical sector. This innovative process involves generating living tissues and organs based on computer-aided design models. Its potential to transform medical treatments is remarkable. By offering the capability to tackle the escalating demand for organ transplants, which currently surpasses the availability of donor organs, 3D bioprinting could usher in a revolutionary approach. This technology presents an ethical and efficient avenue for crafting organs suitable for transplantation. Furthermore, it holds the promise of curtailing the expenses linked with organ transplant procedures. As advancements continue to refine this technology, the 3D bioprinting market is anticipated to witness substantial growth in the years to come.

North America Dominated the 3D Bioprinting Market during the forecast period.

In 2021, the bio 3D printing market in North America secured a prominent share. This achievement was driven by technological progress, escalating research and development undertakings, and improvements in healthcare infrastructure. Furthermore, the region's substantial healthcare spending, the increasing elderly demographic, and the rising prevalence of chronic ailments are all factors boosting the adoption of this technology, particularly within the pharmaceutical sector. Additionally, the year 2021 witnessed an approximate count of 90,000 kidney patients awaiting transplants in the United States, with only 21.4% of them successfully receiving a kidney transplant. Correspondingly, the number of individuals on waiting lists for liver, heart, and lung transplants continues to rise within the country. According to official government statistics, the total tally of individuals awaiting organ transplants exceeded 105,000 in 2021. Tragically, the dearth of available organs for transplantation results in the loss of 17 patients' lives every day. Moreover, North America is observing a rapid surge in its elderly population along with a heightened incidence of orthopedic conditions. These factors are expected to contribute to the growing demand for bio-printed tissues in the region.

On the other hand, the Asia-Pacific region is poised to emerge as the swiftest-expanding market for 3D bioprinting, primarily driven by its substantial consumer base, escalating research and development endeavors in this field, and governmental support coupled with tax incentives. Notably, Chinese researchers have achieved significant progress in this technology, exemplified by the liquid-in-liquid printing process. This approach involves the combination of liquid polymers to produce a stable membrane. These researchers affirm that the resultant liquid structures can retain their form for up to 10 days before undergoing fusion. Through this innovative technique, they have successfully 3D printed intricate shapes, further laying the groundwork for the biofabrication of tissues composed of living cells.

3D Bioprinting Market Scope and Market Size

The 3D Bioprinting Market research report provides an in-depth overview of the industry including market segmentation by Component, Technology, Materials, Application, End-user and Region. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as new product launch, collaborations, expansions, investment analysis, mergers and acquisitions.

3D Bioprinting Market is segmented by region and further by countries, Component, Technology, Materials, Application, End-user and Region. Players, stakeholders, and other participants in the global 3D Bioprinting Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.

Report further studies the market strategies of key players, recent development status, future plans and 3D Bioprinting Market trends across the world. Also, it splits 3D Bioprinting Market Segmentation by material, end-user and region to deep dive research and reveals company profile and prospects.

Major Classifications are as follows:

• By Component
  • 3D Bioprinters
  • Bioinks
• By Technology
  • Stereolithography
  • Selective Laser Sintering
  • Electron Beam Melting
  • Fused Deposition Modeling
  • Laminated Object Manufacturing
  • Inkjet Printing
  • Multi-phase Jet Solidification
• By Materials
  • Living Cells
  • Extracellular Matrices
  • Hydrogels
• By Application
  • Surgical Simulation and Training Models
  • Prosthetic Devices
  • Tissue Engineering and Regenerative Medicine
  • Orthopedic Implants
  • Dental Implants
  • Medical Sensors
  • Others
• By End user
  • Research Organizations & Academic Institutes
  • Biopharmaceutical companies
  • Hospitals
  • Others
• By Region
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa
    • Rest of Middle East & Africa      

Reason to purchase this 3D Bioprinting Market Report:

• Determine prospective investment areas based on a detailed trend analysis of the global 3D Bioprinting Market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different and 3D Bioprinting Market segments in the top spending countries across the world and identify the opportunities offered by each of them.
• Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels that are driving the global 3D Bioprinting Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global 3D Bioprinting Market.
• Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top 3D Bioprinting Market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.